Skip to main content
Clinical Trials/JPRN-UMIN000012617
JPRN-UMIN000012617Completed未知

A study about the impact of intensive instruction on the use of Aricept and the reasons for discontinuation in patients with Alzheimer's Disease - A study about the impact of intensive instruction on the use of Aricept and the reasons for discontinuation in patients with Alzheimer's Disease

Shonan Fujisawa Tokushukai Hospital0 sites150 target enrollmentStarted: December 18, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
150

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1) Patients treated with donepezil, galantamine, rivastigmine in 4 weeks immediately before enrollment 2) Known hypersensitivity to donepezil or piperadine derivatives 3) Involvement in any other investigational drug clinical trial during the preceding 12 weeks

Investigators

Similar Trials